• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Astrazeneca Plc ADR (NQ: AZN )

    79.77 +1.18 (+1.50%)
    Streaming Delayed Price Updated: 3:00 PM EDT, Jul 17, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,118,393
    Open 78.50
    Bid (Size) 79.77 (5)
    Ask (Size) 79.78 (5)
    Prev. Close 78.59
    Today's Range 78.50 - 79.79
    52wk Range 60.47 - 80.86
    Shares Outstanding N/A
    Dividend Yield 1.17%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    European Commission Faces Court Criticism Over COVID Vaccine Contract Transparency Ahead Of Vote on Ursula Von Der Leyen's Reappointment
    European Commission faces scrutiny over COVID vaccine contract transparency ahead of key vote. Legal challenges and implications discussed. 
    Via Benzinga
    Exposures COVID-19
    The 3 Most Undervalued Nasdaq 100 Stocks to Buy in July 2024
    Undervalued Nasdaq 100 stocks may not be as rare as hen's teeth but not quite so plentiful amid a raging bull market. 
    Via InvestorPlace

    Performance

    YTD
    +16.62%
    +16.62%
    1 Month
    +0.58%
    +0.58%
    3 Month
    +16.85%
    +16.85%
    6 Month
    +18.58%
    +18.58%
    1 Year
    +18.97%
    +18.97%

    More News

    Read More
    7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns
    Via InvestorPlace
    United Kingdom Stocks, ETFs To Watch After Keir Starmer, Labour Party Win
    Via Benzinga
    Topics ETFs
    What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
    Via Investor's Business Daily
    3 Set-It-and-Forget-It Stocks for Lasting Financial Security
    Via InvestorPlace
    AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines Agency Accepts Marketing Application Under Accelerated Assessment
    Via Benzinga
    Exposures COVID-19
    7 Biotech Stocks to Boost Your Portfolio to Peak Health
    Via InvestorPlace
    China Approves AstraZeneca's Tagrisso-Chemotherapy Combo Regime For Previously Untreated Lung Cancer Patients
    Via Benzinga
    AstraZeneca's Blockbuster Cancer Drug Imfinzi Flunks As Follow-Up In Type Of Early-Stage Lung Cancer, But Hits Primary Goal In Phase 3 Bladder Cancer Study
    Via Benzinga
    IMFINZI® (durvalumab) demonstrated statistically significant and clinically meaningful improvement in event-free survival and overall survival for muscle-invasive bladder cancer in NIAGARA Phase III trial
    From AstraZeneca
    Via Business Wire
    3 Undervalued Pharma Stocks to Buy for Dividends and Capital Gains
    Via InvestorPlace
    Supreme Court Backs Pharmaceutical Giants in Iraq Terrorism Funding Case
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Legal
    Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success
    Via InvestorPlace
    The 3 Healthiest Healthcare Stocks to Buy for a Huge Dose of Profits
    Via InvestorPlace
    3 No-Brainer Stocks to Buy for Under $100 Right Now
    Via The Motley Fool
    Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
    Via Benzinga
    Eli Lilly's Stock Surge Driven by GLP-1 Demand
    Via MarketBeat
    Topics Economy
    Exposures Interest Rates
    Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
    Via FinancialNewsMedia
    Topics Death
    Exposures Death
    Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
    Via Benzinga
    Exposures COVID-19
    AstraZeneca's Combination Cancer Drug For Advanced Breast Cancer Study Flunks Late-Stage Trial
    Via Benzinga
    Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
    From FN Media Group LLC
    Via GlobeNewswire
    What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday?
    Via Benzinga
    IMFINZI® (durvalumab) plus chemotherapy approved in the US for mismatch repair deficient advanced or recurrent endometrial cancer
    From AstraZeneca
    Via Business Wire
    FDA Approves AstraZeneca Treatment For Advanced Endometrial Cancer
    Via Benzinga
    Exposures Product Safety
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.